In recent trading, shares of Hologic Inc (Symbol: HOLX) have crossed above the average analyst 12-month target price of $46.43, changing hands for …
The weekly MACD oscillator is bullish too. In this Point and Figure chart of HOLX, above, we can see a long rise for this stock. A trade at $47 will be a fresh upside breakout. $54 is the next tentative price target. Bottom line: traders could …
Elaine Ullian, Director disclosed the sale of 8,938 shares of HOLX stock. The shares were purchased at an average price of $43.99. Ullian now owns $1,047,402 of the stock according to the SEC filing. Lawrence M. Levy, Director disclosed …
The following slide deck was published by Hologic, Inc. in conjunction with this …
See Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) latest ratings: The stock of Hologic, Inc. (NASDAQ:HOLX) …
(NASDAQ:HOLX). Art Advsr Ltd Liability Corp accumulated 115,500 shares or 0.28% of the stock. About 21,512 shares traded. Envestnet Inc (NYSE:ENV) has risen 12.71% since June 20, 2016 and is uptrending. It has underperformed by …
6 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for HOLX is $47.53 while analysts mean recommendation is 2.00. Hologic, Inc. (NASDAQ:HOLX) yearly performance is 32.98% and net …
Leading diagnostics player Hologic, Inc. (HOLX - Free Report) recently received FDA approval ... Align Technology has an expected long-term adjusted earnings growth of almost 24.1%. The stock has added roughly 32.3% over the last three …
Director Lawrence M. Levy disclosed the sale of 2,960 shares of HOLX stock. The shares were purchased at an average price of $44.54. Levy now owns $1,900,700 of the stock per the Form 4 SEC filing. Director Elaine Ullian sold 8,938 …